Influence of the serotonin antagonist, metergoline, on the anxiogenic effects of carbon dioxide, and on heart rate and neuroendocrine measures, in healthy volunteers
- 25 April 2001
- journal article
- Published by Wiley in Human Psychopharmacology: Clinical and Experimental
- Vol. 16 (3), 237-245
- https://doi.org/10.1002/hup.259
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Role of 5-HT in stress, anxiety, and depressionPharmacology Biochemistry and Behavior, 1996
- α2-Adrenergic receptor sensitivity in panic disorder: II: Cortisol response to clonidine stimulation in panic disorderPsychoneuroendocrinology, 1995
- Expression of serotonin receptor mRNAs in blood vesselsFEBS Letters, 1995
- 5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: More than 30 years of researchPharmacology & Therapeutics, 1995
- Pharmacologic Effect of Toloxatone on Reactivity to the 35% Carbon Dioxide ChallengeJournal of Clinical Psychopharmacology, 1994
- Functional Correlates of Serotonin 5-HT1Recognition SitesJournal of Receptor Research, 1988
- Endocrine and physiological changes during “spontaneous” panic attacksPsychoneuroendocrinology, 1987
- Co2 inhalation in the treatment of panic attacksBehaviour Research and Therapy, 1986
- Hypercapnia and hypoxia: Chemoreceptor-mediated control of locus coeruleus neurons and splanchnic, sympathetic nervesBrain Research, 1981
- Endocrine Profile and Therapeutic Employment of a New Prolactin-Lowering Drug, MetergolineGynecologic and Obstetric Investigation, 1980